Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.71−0.44 (-1.18%)
Close on Nov 17, 2026Market cap $2.82BP/E 39.9Yield –
Progyny operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Progyny's operating cash flow for the twelve months ending Jun 30, 2026 was $201.25M, down 0.4% year over year. For fiscal 2025 it was $210.19M, up 17.4% from the year before. The highest annual figure on record is $210.19M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $210.19M | +17.4% |
| FY2024 | Dec 31, 2024 | $179.11M | -5.1% |
| FY2023 | Dec 31, 2023 | $188.81M | +134.9% |
| FY2022 | Dec 31, 2022 | $80.40M | +208.8% |
| FY2021 | Dec 31, 2021 | $26.04M | -28.1% |
| FY2020 | Dec 31, 2020 | $36.20M | – |
| FY2019 | Dec 31, 2019 | -$1.53M | -167.5% |
| FY2018 | Dec 31, 2018 | $2.27M | – |
| FY2017 | Dec 31, 2017 | -$9.47M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $50.43M | -9.2% |
| Q1 FY2026 | Mar 31, 2026 | $45.95M | -7.7% |
| Q4 FY2025 | Dec 31, 2025 | $54.20M | +3.9% |
| Q3 FY2025 | Sep 30, 2025 | $50.67M | +13.8% |
| Q2 FY2025 | Jun 30, 2025 | $55.51M | -2.1% |
| Q1 FY2025 | Mar 31, 2025 | $49.81M | +93.6% |
| Q4 FY2024 | Dec 31, 2024 | $52.16M | +38.5% |
| Q3 FY2024 | Sep 30, 2024 | $44.52M | -17.8% |
| Q2 FY2024 | Jun 30, 2024 | $56.69M | -25.4% |
| Q1 FY2024 | Mar 31, 2024 | $25.73M | +22.8% |
| Q4 FY2023 | Dec 31, 2023 | $37.66M | -26.9% |
| Q3 FY2023 | Sep 30, 2023 | $54.18M | +159.3% |
| Q2 FY2023 | Jun 30, 2023 | $76.01M | +294.9% |
| Q1 FY2023 | Mar 31, 2023 | $20.96M | – |
| Q4 FY2022 | Dec 31, 2022 | $51.52M | +484.4% |
| Q3 FY2022 | Sep 30, 2022 | $20.89M | -13.5% |
| Q2 FY2022 | Jun 30, 2022 | $19.25M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.26M | -2216.9% |
| Q4 FY2021 | Dec 31, 2021 | $8.82M | +34.8% |
| Q3 FY2021 | Sep 30, 2021 | $24.16M | +57.6% |
| Q2 FY2021 | Jun 30, 2021 | -$7.47M | -440.1% |
| Q1 FY2021 | Mar 31, 2021 | $532.00K | -95.6% |
| Q4 FY2020 | Dec 31, 2020 | $6.54M | – |
| Q3 FY2020 | Sep 30, 2020 | $15.33M | +160.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.20M | -48.3% |
| Q1 FY2020 | Mar 31, 2020 | $12.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.49M | -234.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.88M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.25M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.17M | – |
| Q4 FY2018 | Dec 31, 2018 | $4.10M | – |
See a number that looks wrong?